Pharmaceuticals, Biotechnology and Life Sciences
Key linker element of Avacta’s novel TMAC™ drug conjugate to be tested in humans within 12 months CAMBRIDGE, England–(BUSINESS WIRE)–Avacta…
BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma, a global leader in medical dermatology, today announced that Gitte Aabo will step down as President…
HONG KONG–(BUSINESS WIRE)–Great Bay Bio, a leading biotechnology company dedicated to innovative drug CMC (Chemistry Manufacturing and Controls) and pre-clinical…
CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge–Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications has closed a further round…
Alecensa reduced the risk of disease progression or death by 63% compared to crizotinib Long-term follow-up reconfirmed that Alecensa prolonged…
New analyses from first-in-human clinical trial presented at the 2019 ASCO Annual Meeting Pivotal trials in metastatic uveal melanoma are…
Primary efficacy analysis demonstrated promising efficacy for capmatinib irrespective of the prior line of therapy in 97 patients: overall response…
Presentation of SENS-111 phase 2 study protocol in Acute Unilateral Vestibulopathy (AUV) MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN)…
– The Phase III POLYP 1 and POLYP 2 studies of Xolair in adults with chronic rhinosinusitis with nasal polyps…
CUPERTINO, Calif.–(BUSINESS WIRE)–Reviva Pharmaceuticals, Inc. (Reviva), a privately held, clinical stage pharmaceutical company today announced that it has successfully completed…